Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new regulatory guidelines that still allow quick COVID vaccine approvals for seniors and the roughly 100–200 million high-risk Americans, but impose costlier randomized, controlled clinical trials only on healthy, low-risk groups. Investors likely saw this update as beneficial, given growing agitation about the potential elimination of COVID boosters, a significant revenue stream for Moderna.
AI Mode will now power AI overviews, which Pichai called “one of the most successful launches for Google Search in the past decade,” leading to 10% growth in queries that show overviews.
In April, Canada’s unemployment rate rose to 6.9%, the highest since September 2021 and 210 basis points above the July 2022 cycle low of 4.8% (shown below since 1950).
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
The court’s action follows a legal complaint filed in March by Bollinger Motors founder Robert Bollinger, who alleged a breach of contract related to a $10 million secured promissory note.
At the beginning of April cumulative 2025 intermodal traffic was higher by 8.7% YoY. Since then almost every week that number has declined, such that last week it was only up 7.9%.
